3 Followers on Owler

AIM ImmunoTech

is a Florida-based pharmaceutical company that researches and develops novel therapeutics for the treatment of cancer and immune-deficiency diseases... Read more
OverviewCompetitorsFundingNews & Insights

AIM ImmunoTech

is a Florida-based pharmaceutical company that researches and develops novel therapeutics for the treatment of cancer and immune-deficiency diseases... Read more
AIM ImmunoTech President & CEO: Thomas K. Equels

President & CEO

Thomas K. Equels

CEO Approval Rating

90/100

1990

PublicNYSEAIM

Pharmaceuticals & Biotechnology
Pharmaceuticals
2836 NAICS listing

Annual Revenue
$ < 1M
Employees
20
Funding
$13.2M

News

Funding
Aug 01, 2025
GlobalNewswire
AIM ImmunoTech received $8M in Post-IPO Equity Funding

AIM ImmunoTech Competitors

1NexImmune
2Aura
3Jounce
Unlock more competitors

Trending Companies